Genetic variation in STAT4 predicts response to interferon-alpha therapy for hepatitis B e antigen-positive chronic hepatitis B.
Jiang DK, Wu X, Qian J, Ma XP, Yang J, Li Z, Wang R, Sun L, Liu F, Zhang P, Zhu X, Wu J, Chen K, Conran C, Zheng SL, Lu D, Yu L, Liu Y, Xu J.
Jiang DK, et al.
Hepatology. 2016 Apr;63(4):1102-11. doi: 10.1002/hep.28423. Epub 2016 Feb 19.
Hepatology. 2016.
PMID: 26704347
Interferon (IFN)-alpha is a first-line therapy for chronic hepatitis B (CHB) patients but only initiates a response in a minority of patients. A genetic variant, rs7574865 in STAT4, was recently reported to be associated with risk …
Interferon (IFN)-alpha is a first-line therapy for chronic hepatitis B (CHB) patients but only initiates a re …